Plant-Based Polyphenol Gels for Arsenic-Induced Hyperpigmentation in Rural Populations

Abstract

Chronic arsenic exposure through contaminated groundwater remains a significant public health concern in rural regions of South Asia, Latin America, and parts of sub-Saharan Africa, where long-term ingestion leads to systemic toxicity and dermatologic manifestations including diffuse and reticulate hyperpigmentation, palmar melanosis, and spotted leukomelanosis. Hyperpigmentation secondary to arsenicosis is often stigmatizing, persistent, and recalcitrant to conventional depigmenting therapies, which are frequently inaccessible or unaffordable in resource-limited settings. Emerging research into the antioxidative and melanogenesis-modulating properties of plant-derived polyphenols suggests a promising therapeutic avenue. Topical formulations containing polyphenols such as epigallocatechin gallate (green tea), curcumin (turmeric), resveratrol (grape seed), and ellagic acid (pomegranate) have demonstrated efficacy in reducing tyrosinase activity, scavenging reactive oxygen species, and downregulating MITF expression in melanocytes—pathways that are upregulated in arsenic-induced pigmentation. A topical gel formulation utilizing locally sourced polyphenol-rich botanicals is proposed for development, optimized for bioavailability, thermal stability, and percutaneous absorption. Preclinical assessment includes in vitro testing on hyperpigmented keratinocyte-melanocyte co-culture models exposed to sodium arsenite, with outcome measures focused on melanin content, oxidative stress markers, and inflammatory cytokine expression. Formulation prototypes will be assessed for rheologic properties, user tolerability, and shelf stability under rural ambient storage conditions. Community-based distribution and future clinical validation in high-exposure regions may offer a culturally acceptable, cost-effective intervention to address visible skin changes that carry social and psychological burdens in arsenic-affected populations. Broader implications include potential integration into public health arsenicosis mitigation programs and promotion of plant-based, regionally appropriate dermatologic therapeutics.